A Collect of Recommendations and Guidelines for Management and Treatment of Underlying Malignancies During the COVID-19 Pandemic
-
Mojgan Karimi-Zarchi
,
Soheila Sayad
,
Mohammad Vakili
,
Ahmad Shirinzadeh-Dastgiri
,
Amirhossein Naseri
,
Mohammad Hossein Antikchi
,
Sepideh Azizi
,
Kazem Aghili
,
Hossein Neamatzadeh
,
Elahe Akbarian
Abstract
The coronavirus disease 2019 (COVID-19) pandemic is the main challenges to public health systems worldwide now. Cancer patients are considered as a high risk group during the COVID-19 pandemic. Considering the evidence so far, cancer as underlying comorbidities might increase the risk of death in patients with COVID-19. Many cancer patients with increased risk of contracting COVID-19 than the general population regularly visit health facilities for treatment and disease surveillance. Thus, the COVID-19 pandemic has a profound impact on cancer care and treatment. Here, we attempted to summarize the current suggestions for handling of cancer patients during COVID-19 pandemic. We carried out a integrative literature review using several online bibliographies. A total of 113 papers were accessed for the time frame between October 05 2020 and October 10 2020. After screening of titles and full-texts, 10 publications were selected in this study. In this work some recommendations and guidelines that would help for management and treatment of cancer for the purpose of address the challenges during COVID-19 pandemic were collected. We hope that this collection recommendations and guidelines assist health care providers in management of individuals with underlying malignancy during the COVID-19 pandemic.
1. Jafari M, Dastgheib SA, Ferdosian F, Mirjalili H, Aarafi H, Noorishadkam M, et al. Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis. Hematol Transfus Cell Ther 2022;44:225-34.
2. Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, Abbasi H, Mirjalili SR, Behforouz A, et al. Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review. Fetal Pediatr Pathol 2020;39:246-50.
3. Karimi-Zarchi M, Schwartz DA, Bahrami R, Dastgheib SA, Javaheri A, Tabatabaiee RS, Ferdosian F, Asadian F, Neamatzadeh H. A meta-analysis for the risk and prevalence of preeclampsia among pregnant women with COVID-19. Turk J Obstet Gynecol 2021;18:224-35.
4. Bahrami R, Schwartz DA, Karimi-Zarchi M, Javaheri A, Dastgheib SA, Ferdosian F, et al. Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19. Turk J Obstet Gynecol 2021;18:236-44.
5. Mirjalili H, Dastgheib SA, Shaker SH, Bahrami R, Mazaheri M, Sadr-Bafghi SMH, et al. Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis. J Diabetes Metab Disord 2021;20:905-17.
6. Jarahzadeh MH, Asadian F, Farbod M, Meibodi B, Abbasi H, Jafari M, et al. Cancer and Coronavirus Disease (COVID-19): Comorbidity, Mechanical Ventilation, and Death Risk. J Gastrointest Cancer 2021;52:80-4.
7. Antikchi MH, Neamatzadeh H, Ghelmani Y, Jafari-Nedooshan J, Dastgheib SA, Kargar S, et al. The Risk and Prevalence of COVID-19 Infection in Colorectal Cancer Patients: a Systematic Review and Meta-analysis. J Gastrointest Cancer 2021;52:73-9.
8. Noorishadkam M, Lookzadeh MH, Mazaheri M, Mirjalili SR, Bahrami R, Asadian F, et al. Coronavirus Disease 2019 (COVID-19) and late Pregnancy Loss in Infected Pregnant Women: A Mini Review. World J Peri Neonatol 2020;2:67-70.
9. Gholi-Nataj M, Rafieian S, Barahman M, Shirinzadeh-Dastgiri A, Vakili M, Ershadi R, et al. A Meta-analysis for Prevalence of Lung Cancer Patients with SARS-CoV-2 Infection during the COVID-19 Pandemic. Eurasian J Med Oncol 2022;6:73-82.
10. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Clin Infect Dis 2021;73:S454-64.
11. Merrill JT, Erkan D, Winakur J, James JA. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol 2020;16:581-9.
12. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol 2020;45:100618.
13. Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J 2020;55:2000547.
14. Yuan B, Liu HQ, Yang ZR, Chen YX, Liu ZY, Zhang K, et al. Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation. Sci Rep 2020;10:11887.
15. Rastad H, Karim H, Ejtahed HS, Tajbakhsh R, Noorisepehr M, Babaei M, et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr 2020;12:57.
16. Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, et al. Clinical Characteristics and Outcomes of COVID-19 Patients with a History of Stroke in Wuhan, China. Stroke 2020;51:2219-23.
17. Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nature Reviews Clinical Oncology. Nat Rev Clin Oncol 2020;17:329-31.
18. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335-7.
19. Ribal MJ, Cornford P, Briganti A, Knoll T, Gravas S, Babjuk M, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol 2020;78:21-8.
20. Ordooei M, Behniafard N, Soheilipour F, Akbarian E. New onset of diabetes in a child infected with COVID-19: a case report. J Diabetes Metab Disord 2021;20:2129-32.
21. Akladios C, Azais H, Ballester M, Bendifallah S, Bolze PA, Bourdel N, et al. Guidelines for surgical management of gynaecological cancer during pandemic COVID-19 period – FRANCOGYN group for the CNGOF. Gynecol Obstet Fertil Senol 2020;48:444-7.
22. Tsamakis K, Gavriatopoulou M, Schizas D, Stravodimou A, Mougkou A, Tsiptsios D, et al. Oncology during the COVID-19 pandemic: Challenges, dilemmas and the psychosocial impact on cancer patients (Review). Oncol Lett 2020;20:441-7
23. Polkowski WP, Sędłak K, Rawicz-Pruszyński K. Treatment of Gastric Cancer Patients During COVID-19 Pandemic: The West is More Vulnerable. Cancer Manag Res 2020;12:6467-76.
24. Lee LYW, Cazier JB, Starkey T, Turnbull CD, Kerr R, Middleton G. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020;395:1919-26.
25. Alhalabi O, Subbiah V. Managing Cancer Care during the COVID-19 Pandemic and Beyond. Trends Cancer 2020;6:533-5.
26. Curigliano G, Banerjee S, Cervantes A, Garassino MC, Garrido P, Girard N, et al. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol 2020;31:1320-35.
27. Bruno W, Haar RJ. A systematic literature review of the ethics of conducting research in the humanitarian setting. Confl Health 2020;14:27.
28. Nielsen MB, Pallesen S, Harris A, Einarsen SV. Protocol for a systematic review and meta-analysis of research on the associations between workplace bullying and sleep. Syst Rev 2018;7:232.
29. Namazi A, Abedinzadeh M, Nourbaksh P, Neamatzadeh H. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: A meta analysis of 5,193 cases and 6,645 controls. Asian Pac J Cancer Prev 2015;16:2263-8.
30. Bernhardt D, Wick W, Weiss SE, Sahgal A, Lo SS, Suh JH, et al. Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas. Neuro Oncol 2020;22:928-35.
31. Wahidi MM, Lamb C, Murgu S, Musani A, Shojaee S, Sachdeva A, et al. American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients with Suspected or Confirmed COVID-19 Infection. J Bronchology Interv Pulmonol 2020;27:e52-4.
32. Hrusak O, Kalina T, Wolf J, Balduzzi A, Provenzi M, Rizzari C, et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Eur J Cancer 2020;132:11-6.
33. Balduzzi A, Brivio E, Rovelli A, Rizzari C, Gasperini S, Melzi ML, et al. Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati. Bone Marrow Transplant 2020;55:1900-5.
34. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med 2020;382:1663-5.
35. Ruggiero A, Romano A, Attinà G. Facing the COVID-19 outbreak in children with cancer. Drugs Context 2020;9:2020-4-12.
36. Baruchel A, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, et al. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE). Bull Cancer 2020;107:629-32.
2. Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, Abbasi H, Mirjalili SR, Behforouz A, et al. Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review. Fetal Pediatr Pathol 2020;39:246-50.
3. Karimi-Zarchi M, Schwartz DA, Bahrami R, Dastgheib SA, Javaheri A, Tabatabaiee RS, Ferdosian F, Asadian F, Neamatzadeh H. A meta-analysis for the risk and prevalence of preeclampsia among pregnant women with COVID-19. Turk J Obstet Gynecol 2021;18:224-35.
4. Bahrami R, Schwartz DA, Karimi-Zarchi M, Javaheri A, Dastgheib SA, Ferdosian F, et al. Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19. Turk J Obstet Gynecol 2021;18:236-44.
5. Mirjalili H, Dastgheib SA, Shaker SH, Bahrami R, Mazaheri M, Sadr-Bafghi SMH, et al. Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis. J Diabetes Metab Disord 2021;20:905-17.
6. Jarahzadeh MH, Asadian F, Farbod M, Meibodi B, Abbasi H, Jafari M, et al. Cancer and Coronavirus Disease (COVID-19): Comorbidity, Mechanical Ventilation, and Death Risk. J Gastrointest Cancer 2021;52:80-4.
7. Antikchi MH, Neamatzadeh H, Ghelmani Y, Jafari-Nedooshan J, Dastgheib SA, Kargar S, et al. The Risk and Prevalence of COVID-19 Infection in Colorectal Cancer Patients: a Systematic Review and Meta-analysis. J Gastrointest Cancer 2021;52:73-9.
8. Noorishadkam M, Lookzadeh MH, Mazaheri M, Mirjalili SR, Bahrami R, Asadian F, et al. Coronavirus Disease 2019 (COVID-19) and late Pregnancy Loss in Infected Pregnant Women: A Mini Review. World J Peri Neonatol 2020;2:67-70.
9. Gholi-Nataj M, Rafieian S, Barahman M, Shirinzadeh-Dastgiri A, Vakili M, Ershadi R, et al. A Meta-analysis for Prevalence of Lung Cancer Patients with SARS-CoV-2 Infection during the COVID-19 Pandemic. Eurasian J Med Oncol 2022;6:73-82.
10. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Clin Infect Dis 2021;73:S454-64.
11. Merrill JT, Erkan D, Winakur J, James JA. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol 2020;16:581-9.
12. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol 2020;45:100618.
13. Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J 2020;55:2000547.
14. Yuan B, Liu HQ, Yang ZR, Chen YX, Liu ZY, Zhang K, et al. Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation. Sci Rep 2020;10:11887.
15. Rastad H, Karim H, Ejtahed HS, Tajbakhsh R, Noorisepehr M, Babaei M, et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr 2020;12:57.
16. Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, et al. Clinical Characteristics and Outcomes of COVID-19 Patients with a History of Stroke in Wuhan, China. Stroke 2020;51:2219-23.
17. Spicer J, Chamberlain C, Papa S. Provision of cancer care during the COVID-19 pandemic. Nature Reviews Clinical Oncology. Nat Rev Clin Oncol 2020;17:329-31.
18. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335-7.
19. Ribal MJ, Cornford P, Briganti A, Knoll T, Gravas S, Babjuk M, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol 2020;78:21-8.
20. Ordooei M, Behniafard N, Soheilipour F, Akbarian E. New onset of diabetes in a child infected with COVID-19: a case report. J Diabetes Metab Disord 2021;20:2129-32.
21. Akladios C, Azais H, Ballester M, Bendifallah S, Bolze PA, Bourdel N, et al. Guidelines for surgical management of gynaecological cancer during pandemic COVID-19 period – FRANCOGYN group for the CNGOF. Gynecol Obstet Fertil Senol 2020;48:444-7.
22. Tsamakis K, Gavriatopoulou M, Schizas D, Stravodimou A, Mougkou A, Tsiptsios D, et al. Oncology during the COVID-19 pandemic: Challenges, dilemmas and the psychosocial impact on cancer patients (Review). Oncol Lett 2020;20:441-7
23. Polkowski WP, Sędłak K, Rawicz-Pruszyński K. Treatment of Gastric Cancer Patients During COVID-19 Pandemic: The West is More Vulnerable. Cancer Manag Res 2020;12:6467-76.
24. Lee LYW, Cazier JB, Starkey T, Turnbull CD, Kerr R, Middleton G. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020;395:1919-26.
25. Alhalabi O, Subbiah V. Managing Cancer Care during the COVID-19 Pandemic and Beyond. Trends Cancer 2020;6:533-5.
26. Curigliano G, Banerjee S, Cervantes A, Garassino MC, Garrido P, Girard N, et al. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol 2020;31:1320-35.
27. Bruno W, Haar RJ. A systematic literature review of the ethics of conducting research in the humanitarian setting. Confl Health 2020;14:27.
28. Nielsen MB, Pallesen S, Harris A, Einarsen SV. Protocol for a systematic review and meta-analysis of research on the associations between workplace bullying and sleep. Syst Rev 2018;7:232.
29. Namazi A, Abedinzadeh M, Nourbaksh P, Neamatzadeh H. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: A meta analysis of 5,193 cases and 6,645 controls. Asian Pac J Cancer Prev 2015;16:2263-8.
30. Bernhardt D, Wick W, Weiss SE, Sahgal A, Lo SS, Suh JH, et al. Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas. Neuro Oncol 2020;22:928-35.
31. Wahidi MM, Lamb C, Murgu S, Musani A, Shojaee S, Sachdeva A, et al. American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients with Suspected or Confirmed COVID-19 Infection. J Bronchology Interv Pulmonol 2020;27:e52-4.
32. Hrusak O, Kalina T, Wolf J, Balduzzi A, Provenzi M, Rizzari C, et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Eur J Cancer 2020;132:11-6.
33. Balduzzi A, Brivio E, Rovelli A, Rizzari C, Gasperini S, Melzi ML, et al. Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati. Bone Marrow Transplant 2020;55:1900-5.
34. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med 2020;382:1663-5.
35. Ruggiero A, Romano A, Attinà G. Facing the COVID-19 outbreak in children with cancer. Drugs Context 2020;9:2020-4-12.
36. Baruchel A, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, et al. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE). Bull Cancer 2020;107:629-32.
| Files | ||
| Issue | Vol 61 No 8 (2023) | |
| Section | Review Article(s) | |
| DOI | https://doi.org/10.18502/acta.v61i8.14900 | |
| Keywords | ||
| COVID-19 Recommendations Gastrointestinal cancer Gynecological cancer Lung cancer Childhood cancer Breast cancer | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Karimi-Zarchi M, Sayad S, Vakili M, Shirinzadeh-Dastgiri A, Naseri A, Antikchi MH, Azizi S, Aghili K, Neamatzadeh H, Akbarian E. A Collect of Recommendations and Guidelines for Management and Treatment of Underlying Malignancies During the COVID-19 Pandemic. Acta Med Iran. 2024;61(8):443-448.
